RE:RE:I like it..Agreed. Will be lucky if the stock can hold around the issue price ($5.55). I don't expect much in the way of positive SP movement until around June 17. Still have 15M in raw materials to process so hopefully they can announce additional deals if that amount is not already spoken for. Australian venture should be good longterm with South Korea and other countries legalizing medical, but money thrown in that direction won't do much for the SP in the short to medium term (Australian facility is still under construction per the 2019 Q1 financials).